SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the audited financial results ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SMS Pharmaceuticals Ltd has informed exchanges that its Board meeting is scheduled for 22nd May 2026. The agenda includes approval of audited standalone and consolidated financial statements for Q4 and the financial year ended 31st March 2026. The Board will also consider recommending dividend for FY 2025-26. The company has closed its trading window from 1st April 2026 to 24th May 2026 as per insider trading regulations, reopening on 25th May 2026. This is a routine quarterly results announcement ahead of the trading window reopening.
This is a standard pre-results announcement notice. Investors should expect the audited Q4 and annual results, along with dividend news, to be released after 22nd May 2026. The closure of the trading window indicates insiders are aware of upcoming material information.